Venus Concept Inc. (NASDAQ:VERO – Get Free Report) saw a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 108,600 shares, a decrease of 92.5% from the October 31st total of 1,450,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average trading volume of 1,780,000 shares, the days-to-cover ratio is currently 0.1 days.
Insiders Place Their Bets
In other news, major shareholder Michael Willingham Masters sold 94,553 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $0.53, for a total value of $50,113.09. Following the completion of the sale, the insider now owns 17,059 shares of the company’s stock, valued at $9,041.27. This represents a 84.72 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 57.98% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC increased its position in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 as of its most recent filing with the Securities and Exchange Commission. 87.41% of the stock is owned by institutional investors and hedge funds.
Venus Concept Trading Up 1.5 %
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Featured Stories
- Five stocks we like better than Venus Concept
- Financial Services Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Warren Buffett Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Stock Profit
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.